Press Releases

Croda announces the new Pharma business

Croda has announced that its Health Care division will now become Croda Pharma, bringing its core speciality excipient portfolio together with the recent acquisition, Avanti...

N4 Pharma highlights potential of Nuvec as gene therapy...

A pre-clinical in-vivo study found that Nuvec® – N4 Pharma’s novel silica-based nanoparticle – formulated with TNF-α pDNA oncotherapy, suppressed tumour growth and improved survival...

Aptamer Group signs deal with Flip Gene Therapeutics to...

Aptamer Group plc, the developer of novel Optimer® binders to enable innovation in the life sciences industry, has negotiated a deal with the biotechnology company...

Achema 2022: Syntegon showcases new solutions for process development...

At this year’s Achema in Frankfurt, Syntegon is presenting new solutions for the production of solid pharmaceutical dosage forms. With the fluid bed laboratory unit...

Crown Bioscience and MBL Enter Joint Venture to Provide...

Crown Bioscience and Medical & Biological Laboratories (MBL), JSR Life Sciences companies, announced the formation of a joint venture, to further expand the provision of...

CPHI China opens for international partnering after China rises...

CPHI & P-MEC China opens its online international partnering platform as pharmaceutical and biopharmaceutical industries in the country report strong underlying conditions and see increases...

CordenPharma Increases xRNA-based Capabilities with a Strategic Investment in...

CordenPharma, a full-service Contract Development Manufacturing Organization (CDMO) of Active Pharmaceutical Ingredients (APIs), Excipients, Drug Products & Packaging services, has increased its xRNA capabilities at...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read